Spyre Therapeutics
SYRE
#5838
Rank
A$1.27 B
Marketcap
$21.15
Share price
-8.58%
Change (1 day)
-60.61%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -$109.38

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$119.39. In 2023 the company made an earnings per share (EPS) of -$81.24 a decrease over its 2022 EPS that were of -$40.94.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$109.3834.63%
2023-$81.2498.46%
2022-$40.94-1%
2021-$41.35-34.21%
2020-$62.85-37.96%
2019-$101.3115.02%
2018-$88.0818.33%
2017-$74.43-18.92%
2016-$91.80120.2%
2015-$41.69-33.55%
2014-$62.73